Skip to main content

Adenosine Deaminase Deficiency News

Related terms: ADA Deficiency

FDA Approves Revcovi (elapegademase-lvlr) for Adenosine Deaminase Severe Combined Immune Deficiency (ADA-SCID)

GAITHERSBURG, Md.--(BUSINESS WIRE) October 05, 2018 --Leadiant Biosciences, Inc. today announced that the Food and Drug Administration (FDA) has granted approval to Revcovi™ (elapegademase-lvlr) i...

Ask a question

To post your own question to this support group, sign in or create an account.